ÂÜÀòÂÒÂ×

Biomedical research scientist Stephen Judd represents a unique kind of entrepreneur. Having spent 25 years in business development, product management and strategic planning within both start-up and large corporate environments, the Axenia Biologix founder used his extensive knowledge to establish a Dixon, CA-based contract manufacturer for cell culture sera and reagents in 2009. Not satisfied with the way some manufacturers were failing to disclose what their products contained or their geographic origins, Judd was instrumental in helping to form the International Serum Industry Association (ISIA), raising the bar on FBS manufacturing transparency and disclosure worldwide. ISIA Chairman-elect, Judd partners with others to continue the development of the association’s stakeholder value.